[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Onychomycosis (Tinea Unguium) Drug Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 121 pages | ID: GA51732037AEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate. Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

SCOPE OF THE REPORT:

This report studies the Onychomycosis (Tinea Unguium) Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Onychomycosis (Tinea Unguium) Drug market by product type and applications/end industries.
The classification of Onychomycosis (Tinea Unguium) Drug Oral medication and External medicine, and the proportion of Oral medication in 2016 is about 76.24% market share is in decrease trend.
Onychomycosis (Tinea Unguium) Drug are widely used for Age under 18, Age 18-50 and Age above 50 treatment. The most proportion of consumer is in Age 18-50, and the market share in 2016 is 82.66%.
USA is the largest consumption place, with a consumption market share nearly 33.14% in 2016. Following USA, Europe is the second largest consumption place with the consumption market share of 23.66%.
The global Onychomycosis (Tinea Unguium) Drug market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Onychomycosis (Tinea Unguium) Drug.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
  • Johnson & Johnson
  • GSK
  • Novartis
  • Pfizer
  • Valeant Pharma
  • Kaken Pharmaceutical
  • Galderma
  • Xiuzheng Pharmaceutical
  • Letai
  • Qilu Pharmaceutical
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Oral Medication
  • External Medicine
Market Segment by Applications, can be divided into
  • Age Under 18
  • Age 18-50
  • Age Above 50
1 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Classification of Onychomycosis (Tinea Unguium) Drug by Types
  1.2.1 Global Onychomycosis (Tinea Unguium) Drug Revenue Comparison by Types (2017-2023)
  1.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Types in 2017
  1.2.3 Oral Medication
  1.2.4 External Medicine
1.3 Global Onychomycosis (Tinea Unguium) Drug Market by Application
  1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Age Under
  1.3.3 Age 18-50
  1.3.4 Age Above
1.4 Global Onychomycosis (Tinea Unguium) Drug Market by Regions
  1.4.1 Global Onychomycosis (Tinea Unguium) Drug Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Onychomycosis (Tinea Unguium) Drug Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Onychomycosis (Tinea Unguium) Drug Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Onychomycosis (Tinea Unguium) Drug Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Onychomycosis (Tinea Unguium) Drug Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Onychomycosis (Tinea Unguium) Drug Status and Prospect (2013-2023)
1.5 Global Market Size of Onychomycosis (Tinea Unguium) Drug (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Johnson & Johnson
  2.1.1 Business Overview
  2.1.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
  2.2.1 Business Overview
  2.2.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 GSK Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
  2.3.1 Business Overview
  2.3.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valeant Pharma
  2.5.1 Business Overview
  2.5.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kaken Pharmaceutical
  2.6.1 Business Overview
  2.6.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.7 Galderma
  2.7.1 Business Overview
  2.7.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.8 Xiuzheng Pharmaceutical
  2.8.1 Business Overview
  2.8.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.9 Letai
  2.9.1 Business Overview
  2.9.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Letai Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
2.10 Qilu Pharmaceutical
  2.10.1 Business Overview
  2.10.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET COMPETITION, BY PLAYERS

3.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Onychomycosis (Tinea Unguium) Drug Players Market Share
  3.2.2 Top 10 Onychomycosis (Tinea Unguium) Drug Players Market Share
3.3 Market Competition Trend

4 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SIZE BY REGIONS

4.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Regions
4.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
4.3 Europe Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
4.5 South America Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG REVENUE BY COUNTRIES

5.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
5.2 USA Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
5.3 Canada Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
5.4 Mexico Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

6 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG REVENUE BY COUNTRIES

6.1 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
6.2 Germany Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
6.3 UK Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
6.4 France Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
6.5 Russia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
6.6 Italy Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG REVENUE BY COUNTRIES

7.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
7.2 China Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
7.3 Japan Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
7.4 Korea Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
7.5 India Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG REVENUE BY COUNTRIES

8.1 South America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
8.2 Brazil Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
8.3 Argentina Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
8.4 Colombia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY COUNTRIES

9.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
9.2 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
9.3 UAE Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
9.4 Egypt Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
9.5 Nigeria Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
9.6 South Africa Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

10 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENT BY TYPE

10.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2013-2018)
10.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2018-2023)
10.3 Oral Medication Revenue Growth Rate (2013-2023)
10.4 External Medicine Revenue Growth Rate (2013-2023)

11 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENT BY APPLICATION

11.1 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2013-2018)
11.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2018-2023)
11.3 Age Under 18 Revenue Growth (2013-2018)
11.4 Age 18-50 Revenue Growth (2013-2018)
11.5 Age Above 50 Revenue Growth (2013-2018)

12 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SIZE FORECAST (2018-2023)

12.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Forecast (2018-2023)
12.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Regions (2018-2023)
12.3 North America Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)
12.4 Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)
12.6 South America Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source



LIST OF TABLES AND FIGURES

Figure Onychomycosis (Tinea Unguium) Drug Picture
Table Product Specifications of Onychomycosis (Tinea Unguium) Drug
Table Global Onychomycosis (Tinea Unguium) Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Types in 2017
Figure Oral Medication Picture
Figure External Medicine Picture
Table Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Application (2013-2023)
Figure Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Applications in 2017
Figure Age Under 18 Picture
Figure Age 18-50 Picture
Figure Age Above 50 Picture
Table Global Market Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Onychomycosis (Tinea Unguium) Drug Type and Applications
Table GSK Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharma Basic Information, Manufacturing Base and Competitors
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Galderma Basic Information, Manufacturing Base and Competitors
Table Galderma Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Galderma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Xiuzheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Letai Basic Information, Manufacturing Base and Competitors
Table Letai Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Letai Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2016-2017)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Players (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Players (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Players in 2016
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Players in 2017
Figure Global Top 5 Players Onychomycosis (Tinea Unguium) Drug Revenue Market Share in 2017
Figure Global Top 10 Players Onychomycosis (Tinea Unguium) Drug Revenue Market Share in 2017
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Regions (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Regions (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Regions (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Regions in 2017
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure USA Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Countries (2013-2018)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure Germany Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure UK Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure France Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Russia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Italy Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure China Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Japan Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Korea Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure India Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure Brazil Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Argentina Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Colombia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure UAE Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Egypt Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Nigeria Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure South Africa Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Type (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type in 2017
Table Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Type (2018-2023)
Figure Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2018-2023)
Figure Global Oral Medication Revenue Growth Rate (2013-2018)
Figure Global External Medicine Revenue Growth Rate (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue by Application (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Application in 2017
Table Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Application (2018-2023)
Figure Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2018-2023)
Figure Global Age Under 18 Revenue Growth Rate (2013-2018)
Figure Global Age 18-50 Revenue Growth Rate (2013-2018)
Figure Global Age Above 50 Revenue Growth Rate (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Forecast (2018-2023)


More Publications